Anderson Hoagland & Co. Makes New $1.66 Million Investment in Kenvue Inc. (NYSE:KVUE)

Anderson Hoagland & Co. purchased a new stake in Kenvue Inc. (NYSE:KVUE) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 78,494 shares of the company’s stock, valued at approximately $1,656,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Huntington National Bank boosted its holdings in Kenvue by 26.5% in the third quarter. Huntington National Bank now owns 4,161 shares of the company’s stock valued at $96,000 after acquiring an additional 871 shares during the last quarter. ING Groep NV boosted its stake in shares of Kenvue by 23.6% in the 3rd quarter. ING Groep NV now owns 3,576,616 shares of the company’s stock valued at $82,727,000 after purchasing an additional 681,954 shares during the last quarter. Everence Capital Management Inc. increased its position in shares of Kenvue by 122.1% during the fourth quarter. Everence Capital Management Inc. now owns 45,380 shares of the company’s stock worth $969,000 after buying an additional 24,950 shares during the period. Saturna Capital Corp increased its position in shares of Kenvue by 29.9% during the third quarter. Saturna Capital Corp now owns 1,334,860 shares of the company’s stock worth $30,875,000 after buying an additional 307,039 shares during the period. Finally, Tyler Stone Wealth Management raised its stake in Kenvue by 134.4% during the third quarter. Tyler Stone Wealth Management now owns 49,050 shares of the company’s stock worth $1,135,000 after buying an additional 28,125 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on the company. UBS Group decreased their price target on Kenvue from $24.00 to $23.00 and set a “neutral” rating for the company in a report on Thursday, January 16th. Bank of America raised their target price on Kenvue from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Tuesday, October 22nd. Piper Sandler raised Kenvue from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $21.00 to $26.00 in a research note on Monday, January 6th. Royal Bank of Canada upgraded Kenvue from a “hold” rating to a “moderate buy” rating in a report on Monday, December 9th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Kenvue from a “buy” rating to a “hold” rating and dropped their target price for the company from $25.00 to $24.00 in a research report on Thursday, December 12th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, Kenvue presently has an average rating of “Hold” and a consensus target price of $23.08.

Kenvue Stock Performance

KVUE opened at $20.79 on Friday. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $24.46. The company has a market cap of $39.85 billion, a price-to-earnings ratio of 37.79, a PEG ratio of 1.99 and a beta of 1.46. The company’s fifty day moving average price is $22.14 and its two-hundred day moving average price is $21.78. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.01. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The business had revenue of $3.90 billion for the quarter, compared to analysts’ expectations of $3.92 billion. During the same quarter last year, the firm earned $0.31 EPS. The firm’s revenue for the quarter was down .4% compared to the same quarter last year. On average, analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th will be given a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a yield of 3.95%. The ex-dividend date is Wednesday, February 12th. Kenvue’s payout ratio is currently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.